This inventor holds 2 USPTO granted patents. Top assignee: Medical Diagnostic Laboratories, LLC. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: Innovations by David W Hilbert
Introduction
David W Hilbert is an accomplished inventor based in Burlington, NJ (US). He has made significant contributions to the field of medical diagnostics, particularly in understanding metronidazole resistance in Trichomonas vaginalis. With a total of 2 patents, his work has implications for improving treatment strategies in infectious diseases.
Latest Patents
Hilbert's latest patents focus on the discovery of single nucleotide polymorphisms (SNPs) associated with metronidazole resistance. The presence of specific SNPs, such as G76C, C213G, or C318A in tvntr 4, and A238T, G427C, or T476C in tvntr6, serves as reliable biomarkers for identifying metronidazole-resistant strains. These inventions also provide reagents for detecting these SNPs, facilitating the screening of subjects for metronidazole resistance.
Career Highlights
Hilbert is currently associated with Medical Diagnostic Laboratories, LLC, where he continues to advance his research and innovations. His work has been pivotal in enhancing the understanding of genetic factors that contribute to drug resistance in pathogens.
Collaborations
Throughout his career, Hilbert has collaborated with notable colleagues, including Scott E Gygax and Martin E Adelson. These partnerships have fostered a collaborative environment that promotes innovative research and development in the field of medical diagnostics.
Conclusion
David W Hilbert's contributions to the field of medical diagnostics through his patents and collaborations highlight his role as a significant inventor. His work on metronidazole resistance is crucial for advancing treatment options and improving patient outcomes.